Pharmacokinetics of once-daily venlafaxine extended release in healthy volunteers
Authors:
Open Access
- 1 August 1997
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 58 (8) , 504-514
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Venlafaxine oxidationin vitrois catalysed by CYP2D6British Journal of Clinical Pharmacology, 1996
- A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatientsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1996
- Long-Term Safety and Clinical Acceptability ofJournal of Clinical Psychopharmacology, 1994
- A High-Performance Liquid Chromatographic Method for the Simultaneous Determination of Venlafaxine and O-Desmethylvenlafaxine in Biological FluidsTherapeutic Drug Monitoring, 1994
- Metabolic disposition of14C-venlafaxine in mouse, rat, dog, rhesus monkey and manXenobiotica, 1993
- Introduction of a Composite Parameter to the Pharmacokinetics of Venlafaxine and its Active O‐Desmethyl MetaboliteThe Journal of Clinical Pharmacology, 1992
- Biochemical, neurophysiological, and behavioral effects of Wy‐45,233 and other identified metabolites of the antidepressant venlafaxineDrug Development Research, 1991
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivativeBiochemical Pharmacology, 1986
- The Effect of Food on Drug BioavailabilityAnnual Review of Pharmacology and Toxicology, 1980